Stratus OCT quality control in two multi-centre multiple sclerosis clinical trials

Neuro-Ophthalmology

Volumn 35, Issue 2, 2011, Pages 57-64

  Keltner, John L ^a,b   Cello, Kimberly E ^a   Balcer, Laura J ^c   Calabresi, Peter A ^d   Markowitz, Clyde E ^c   Werner, John S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Multiple sclerosis; neuro ophthalmology; OCT; quality control; reading centre

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CLINICAL TRIAL (TOPIC); HUMAN; LABORATORY PERSONNEL; MULTIPLE SCLEROSIS; OPTIC DISK; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; QUALITY CONTROL; RETINA FOVEA;

EID: 79952952396     PISSN: 01658107     EISSN: 1744506X     Source Type: Journal    
DOI: 10.3109/01658107.2011.557760     Document Type: Article

References (31)

1. Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway-Heath DF, Thompson AJ, Plant GT, Miller DH. Retinal nerve fibre layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005;58:383-391. (Pubitemid 41266624)
2. Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI, Freedman MS, Zackon DH, Kardon RH. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006;59:963-969. (Pubitemid 43830928)
3. Noval S, Contreras I, Rebolleda G, Munoz-Negrete F. Optical coherence tomography in optic neuritis [letter]. Ophthalmology 2007;114:200. (Pubitemid 46014313)
4. Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM, Winslow H, Frohman TC, Calabresi PA, Maguire MG, Cutter GR, Balcer LJ. Relation of visual function in retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006;113:324-332. (Pubitemid 43170783)
5. Sergott RC. Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis. Curr Opin Ophthalmol 2005;16:346-350. (Pubitemid 41735824)
6. Frohman EM, Fujimoto JG, Frohman T, Calabresi PA, Cutter G, Balcer LJ. Optical coherence tomography: A window into the mechanism of multiple sclerosis. Nature Clinical Practice Neurology 2008;4:664-675.
7. Talman LS, Bisker ER, Sacket DJ, Long DA Jr, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ, Remington G, Conger A, Frohman TC, Jacobs DA, Markowitz CE, Cutter GR, Ying GA, Dal Y, Maguire MG, Galetta SL, Frohman EM, Calabresi PA, Balcer LJ. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 2010;67:749-760.
8. Keltner JL, Johnson CA, Beck RW, Cleary PA, Spurr JO, Optic Neuritis Study Group. Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT). Controlled Clin Trials 1993;14:143-159. (Pubitemid 23102302)
9. Keltner JL Johnson CA, Cello KE, Bandermann SE, Fan JJ, Levine RA, Kass MA, Gordon MO, and the Ocular Hypertension Treatment Study Group. Visual field quality control in the Ocular Hypertension Treatment Study (OHTS). J Glaucoma 2007;16:665-669. (Pubitemid 350307626)
10. Keltner JL, Johnson CA, Cello KE, Dontchev M, Gal RL, Beck RW, for the Optic Neuritis Study Group. Visual field profile of optic neurtis. A final follow-up report from the Optic Neuritis Treatment Trial from baseline through 15 years. Arch Ophthalmol 2010;128:330-337.
11. Keltner JL, Johnson CA, Cello KE, Edwards MA, Bandermann SE, Kass MA, Gordon MO for the OHTS Study Group. Classification of visual field abnormalities in the Ocular Hypertension Treatment Study. Arch Ophthalmol 2003;121:643-650. (Pubitemid 36554466)
12. Domalpally A, Blodi BA, Scott IU, Ip MS, Oden JL, Lauer AK, and VanVeldhuisen PC for the SCORE Study Investigator Group. The standard care vs corticosteroid for retinal vein occlusion (SCORE) study system for evaluation of optical coherence tomograms. Arch Ophthalmol 2009;127:1461-1467.
13. Costa RA, Calucci D, Skaf M, Cardillo JA, Castro JC, Melo LA, Martins MC, Kaiser PK. Optical coherence tomography 3: automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. Invest Ophthalmol Vis Sci 2004;45:2399-2406. (Pubitemid 38902615)
14. Ishikawa H, Piette S, Liebmann JM, Ritch R. Detecting the inner and outer borders of the retinal nerve fiber layer using optical coherence tomography. Graefe's Arch Clin Exp Ophthalmol 2002;240:362-371. (Pubitemid 36075610)
15. Wu Z, Vazeen M, Varma R, Chopra V, Walsh AC, LaBree LD, Sadda SR. Factors associated with variability in retinal nerve fiber layer thickness measurements obtained by optical coherence tomography. Ophthalmology 2007;114:1505-1512. (Pubitemid 47126592)
16. Ray R, Stinnett SS, Jaffe GJ. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. Am J Ophthalmol 2005;139:18-29. (Pubitemid 40094836)
17. Sadda SR, Wu Z, Walsh AC, Richine L, Dougall J, Cortez R, LaBree LD. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology 2006;113:285-293. (Pubitemid 43170778)
18. Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 2007;69:2085-2092. (Pubitemid 350175711)
19. Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, García-Layana A, Bejarano B, Villoslada P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007;68:1488-1494. (Pubitemid 46685919)
20. Cettomai D, Pulicken M, Gordon-Lipkin E, Salter A, Frohman TC, Conger A, Zhang X, Cutter G, Balcer LJ, Frohman EM, Calabresi PA. Reproducibility of optical coherence tomography in multiple sclerosis. Arch Neurol 2008;65:1218-1222.
21. Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, Calabresi PA, Kerr D. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 2009;73:302-308.
22. Patella VM. Establishment of Normative Reference Values for Retinal Never Fiber Layer Thickness Measurements. 2003. White paper. Carl Zeiss Meditec, Inc.
23. Carl Zeiss Meditec, Inc. Stratus OCT Model 3000 Users Manual PN 2660021130591 REV A. 2003.
24. McDonald WI, Barnes D. The ocular manifestation of multiple sclerosis, I: abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry 1992;55:747-752.
25. Warner J, Lessell S. Neuro-ophthalmology of multiple sclerosis. Clin Neurosci 1994;2:180-188.
26. Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, Bucci MG, Pierelli F. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999;40:2520-2527. (Pubitemid 29455479)
27. Frohman EM, Dwyer MG, Frohman T, Cox JL, Salter A, Greenberg BM, Hussein S, Conger A, Calabresi P, Balcer LJ, Zivadinov R. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fibre layer thickness, as assessed by OCT and GDx: a pilot study. J Neurol Sci 2009;282:96-105.
28. Trip SA, Schlottmann PG, Jones SJ, Li WY, Garway-Heath DF, Thompson AJ, Plant GT, Miller DH. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 2006;31:286-293. (Pubitemid 43728985)
29. Van Buren JM. The Retinal Ganglion Cell Layer. Springfield: Charles C., Thomas, 1963.
30. Cheung CY, Leung CK, Lin D, Pang CP, Lam DS. Relationship between retinal nerve fiber layer measurement and signal strength in optical coherence tomography. Ophthalmology 2008;115:1347-1351.
31. Domalpally A, Danis RP, Zhang B, Myers D, Kruse CN. Quality issues in interpretation of optical coherence tomograms in macular diseases. Retina 2009;29: 775-781.